Liposome Tech, Vestar Inc. news

The New York company will cut its staff to 65 from 85 over the next few months. CEO Haim Aviv told BioCentury that more cuts will be made on the discovery side than on the development side. PARS will close its New York division, which housed a nine-person staff for accounting and finance. ...